Ligand Earns $6 Million as OmniAb Partner Out-Licenses Antibody Projects

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 9/2/2026

1. PANW
2. GTLB
3. DELL
4. MDB
5. GOOGL
6. SPY
7. HPE
8. USO
9. SNOW
10. MMED

Go back to Ligand Earns $6 Million as OmniAb Partner Out-Licenses Antibody Projects
LIGAND PHARMA (NASDAQ: LGND) Delayed: 286.92 +2.65 (0.93%)
Previous Close $284.27    52 Week High $139.79 
Open $285.73    52 Week Low $82.07 
Day High $290.33    P/E 667.26 
Day Low $281.69    EPS $0.43 
Volume 189,613